金城医药：关于子公司获得药品补充申请批准通知书的公告

Core Viewpoint - Jincheng Pharmaceutical announced that its wholly-owned subsidiary, Beijing Jincheng Tail Pharmaceutical Co., Ltd., has received a drug supplement application approval notice from the National Medical Products Administration for the product named Progesterone Cream [2] Group 1 - The approval is significant for the company's product portfolio and may enhance its market position in the pharmaceutical industry [2] - The product, Progesterone Cream, is expected to contribute to the company's revenue growth following the approval [2]